SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celera Genomics (CRA) -- Ignore unavailable to you. Want to Upgrade?


To: Jerry Miller who wrote (182)3/21/2000 5:57:00 PM
From: BigAppleBoy  Respond to of 746
 
As I stated before,On March 24 will be an article about the first ever mapping of a fruit fly....as far as the stock split it has been approved but will be announce in April the same time with earnings.The split will take place in July for the shareholders of the end of June.
It is really a shame that CRA it is trading at 100 but I have seen this before with many good stocks,after all the whole stock market is nothing more than a pump & dump.Dean Witter has propably spend over 100 million in stock, buying CRA shares the past few days just to support it,but some smaller institutions are still dumping,not because anything change with the fundementals but because all this negativity creates a good opportunity to take profits without anybody asking questions.
Like I said before,it is all a pump & dump



To: Jerry Miller who wrote (182)3/21/2000 5:59:00 PM
From: Jeffry K. Smith  Respond to of 746
 
I called Celera today and talked to an "Ed Block" (I believe) in IR. Asked "how is CRA going to make money off what they have discovered".

I'm sure all of you on this thread know the answer, but I pummeled him with questions for 1/2 hour, and was quite pleased. He could not confirm the April buy time for employee stock.

Ultimately I ended up buyings HGSI and selling cc's on it. Thanks to those of you here, and those I have communicated with regarding CRA and HGSI. I'm not sure if/how I will get into CRA.

Best,
Jeff Smith